<?xml version="1.0" encoding="UTF-8"?>
<p>Given the fact that SARS-CoV-2 invades cells through the ACE2 receptor, the use of ACE inhibitors (ACEis) and angiotensin II receptor blockers (ARBs) has become controversial. The unproven hypothesis is that ACE2 is overexpressed in these patients, giving more ports of entry for the virus [
 <xref rid="sfaa082-B33" ref-type="bibr">33</xref>].
</p>
